Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1994 Mar 12;308(6930):681–686. doi: 10.1136/bmj.308.6930.681

Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project.

U Lindblad 1, L Råstam 1, L Rydén 1, J Ranstam 1, S O Isacsson 1, G Berglund 1
PMCID: PMC2539409  PMID: 8142790

Abstract

OBJECTIVE--To analyse the relation between treated blood pressure and concomitant risk factor and morbidity from acute myocardial infarction. DESIGN--Prospective longitudinal study. Treated blood pressures and other variables were used to predict acute myocardial infarction. SETTING--Primary health care in Skaraborg, Sweden. SUBJECTS--1121 men and 1453 women aged 40-69 years at registration at outpatient clinics, 1977-81, with no evidence of previous myocardial infarction were followed up for an average of 7.4 years. Subjects were undergoing treatment with drugs to lower blood pressure or had blood pressure that exceeded the systolic or diastolic limits, or both, for diagnosis (> 170/> 105 mm Hg (patients aged 40-60 years) and > 180/> 110 mm Hg (older than 60 years)) on three different occasions, or both. MAIN OUTCOME MEASURES--First validated event of fatal or non-fatal acute myocardial infarction. RESULTS--In men but not in women there was a negative relation between treated diastolic blood pressure and risk of acute myocardial infarction. Left ventricular hypertrophy and smoking were contributory risk factors in both sexes, as was serum cholesterol concentration in men. In men with normal electrocardiograms (n = 345) risk increased with increasing diastolic blood pressure (P = 0.047), whereas the opposite was found in men with electrocardiograms suggesting ischaemia or hypertrophy, or both (n = 499, P = 0.009). In those with a reading of 95-99 mm Hg the relative risk was 0.30 (P = 0.034); at > or = 100 mm Hg it was 0.37 (P = 0.027). No similar relations were seen in women or for systolic blood pressure. CONCLUSION--It may be hazardous to lower diastolic blood pressure below 95 mm Hg in hypertensive men with possible ischaemia or hypertrophy, or both. Electrocardiographic findings should be considered when treatment goals are decided for men with hypertension.

Full text

PDF
681

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman M. H., Ooi W. L., Madhavan S., Cohen H. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA. 1989 Aug 18;262(7):920–924. [PubMed] [Google Scholar]
  2. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  3. Anderson T. W. Re-examination of some of the Framingham blood-pressure data. Lancet. 1978 Nov 25;2(8100):1139–1141. doi: 10.1016/s0140-6736(78)92288-2. [DOI] [PubMed] [Google Scholar]
  4. Berglund G. Goals of antihypertensive therapy. Is there a point beyond which pressure reduction is dangerous? Am J Hypertens. 1989 Jul;2(7):586–593. doi: 10.1093/ajh/2.7.586. [DOI] [PubMed] [Google Scholar]
  5. Berglund G., Isacsson S. O., Rydén L. The Skaraborg project--a controlled trial regarding the effect of structured hypertension care. Acta Med Scand Suppl. 1979;626:64–68. [PubMed] [Google Scholar]
  6. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
  7. Cooper S. P., Hardy R. J., Labarthe D. R., Hawkins C. M., Smith E. O., Blaufox M. D., Cooper C. J., Entwisle G., Maxwell M. H. The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-Up Program. Am J Epidemiol. 1988 Feb;127(2):387–403. doi: 10.1093/oxfordjournals.aje.a114812. [DOI] [PubMed] [Google Scholar]
  8. Cruickshank J. M. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ. 1988 Nov 12;297(6658):1227–1230. doi: 10.1136/bmj.297.6658.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cruickshank J. M., Thorp J. M., Zacharias F. J. Benefits and potential harm of lowering high blood pressure. Lancet. 1987 Mar 14;1(8533):581–584. doi: 10.1016/s0140-6736(87)90231-5. [DOI] [PubMed] [Google Scholar]
  10. D'Agostino R. B., Belanger A. J., Kannel W. B., Cruickshank J. M. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ. 1991 Aug 17;303(6799):385–389. doi: 10.1136/bmj.303.6799.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Devereux R. B., Alonso D. R., Lutas E. M., Gottlieb G. J., Campo E., Sachs I., Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986 Feb 15;57(6):450–458. doi: 10.1016/0002-9149(86)90771-x. [DOI] [PubMed] [Google Scholar]
  12. Dunn F. G., McLenachan J., Isles C. G., Brown I., Dargie H. J., Lever A. F., Lorimer A. R., Murray G. D., Pringle S. D., Robertson J. W. Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic. J Hypertens. 1990 Aug;8(8):775–782. doi: 10.1097/00004872-199008000-00012. [DOI] [PubMed] [Google Scholar]
  13. Farnett L., Mulrow C. D., Linn W. D., Lucey C. R., Tuley M. R. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA. 1991 Jan 23;265(4):489–495. [PubMed] [Google Scholar]
  14. Fletcher A. E., Bulpitt C. J. How far should blood pressure be lowered? N Engl J Med. 1992 Jan 23;326(4):251–254. doi: 10.1056/NEJM199201233260407. [DOI] [PubMed] [Google Scholar]
  15. Frohlich E. D., Apstein C., Chobanian A. V., Devereux R. B., Dustan H. P., Dzau V., Fauad-Tarazi F., Horan M. J., Marcus M., Massie B. The heart in hypertension. N Engl J Med. 1992 Oct 1;327(14):998–1008. doi: 10.1056/NEJM199210013271406. [DOI] [PubMed] [Google Scholar]
  16. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med. 1980 Nov;69(5):725–732. doi: 10.1016/0002-9343(80)90438-6. [DOI] [PubMed] [Google Scholar]
  17. Kannel W. B. Status of risk factors and their consideration in antihypertensive therapy. Am J Cardiol. 1987 Jan 23;59(2):80A–90A. doi: 10.1016/0002-9149(87)90182-2. [DOI] [PubMed] [Google Scholar]
  18. Levy D., Anderson K. M., Savage D. D., Kannel W. B., Christiansen J. C., Castelli W. P. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med. 1988 Jan;108(1):7–13. doi: 10.7326/0003-4819-108-1-7. [DOI] [PubMed] [Google Scholar]
  19. Levy D., Labib S. B., Anderson K. M., Christiansen J. C., Kannel W. B., Castelli W. P. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990 Mar;81(3):815–820. doi: 10.1161/01.cir.81.3.815. [DOI] [PubMed] [Google Scholar]
  20. Lindblad U., Råstam L., Ranstam J. Acute myocardial infarction in patients treated for hypertension in the Skaraborg Hypertension Project. Eur Heart J. 1993 Mar;14(3):291–296. doi: 10.1093/eurheartj/14.3.291. [DOI] [PubMed] [Google Scholar]
  21. Lindblad U., Råstam L., Ranstam J., Peterson M. Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med. 1993 Mar;21(1):3–9. doi: 10.1177/140349489302100102. [DOI] [PubMed] [Google Scholar]
  22. Lindblad U., Råstam L., Ranstam J. Stroke morbidity in patients treated for hypertension--The Skaraborg Hypertension Project. J Intern Med. 1993 Feb;233(2):155–163. doi: 10.1111/j.1365-2796.1993.tb00668.x. [DOI] [PubMed] [Google Scholar]
  23. Råstam L., Berglund G., Isacsson S. O., Rydén L. The Skaraborg hypertension project. II. Feasibility of a medical care program for hypertension. Acta Med Scand. 1986;219(3):249–260. [PubMed] [Google Scholar]
  24. Råstam L., Berglund G., Isacsson S. O., Rydén L. The Skaraborg hypertension project. III. Influence on blood pressure of a medical care program for hypertension. Acta Med Scand. 1986;219(3):261–269. [PubMed] [Google Scholar]
  25. SOKOLOW M., LYON T. P. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949 Feb;37(2):161–186. doi: 10.1016/0002-8703(49)90562-1. [DOI] [PubMed] [Google Scholar]
  26. Samuelsson O. G., Wilhelmsen L. W., Pennert K. M., Wedel H., Berglund G. L. The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden. J Hypertens. 1990 Jun;8(6):547–555. doi: 10.1097/00004872-199006000-00008. [DOI] [PubMed] [Google Scholar]
  27. Samuelsson O. Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care. Acta Med Scand Suppl. 1985;702:1–79. [PubMed] [Google Scholar]
  28. Samuelsson O., Wilhelmsen L., Andersson O. K., Pennert K., Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden. JAMA. 1987 Oct 2;258(13):1768–1776. [PubMed] [Google Scholar]
  29. Strandgaard S., Haunsø S. Why does antihypertensive treatment prevent stroke but not myocardial infarction? Lancet. 1987 Sep 19;2(8560):658–661. doi: 10.1016/s0140-6736(87)92444-5. [DOI] [PubMed] [Google Scholar]
  30. Waller P. C., Isles C. G., Lever A. F., Murray G. D., McInnes G. T. Does therapeutic reduction of diastolic blood pressure cause death from coronary heart disease? J Hum Hypertens. 1988 Jun;2(1):7–10. [PubMed] [Google Scholar]
  31. Wilhelmsen L., Berglund G., Elmfeldt D., Fitzsimons T., Holzgreve H., Hosie J., Hörnkvist P. E., Pennert K., Tuomilehto J., Wedel H. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens. 1987 Oct;5(5):561–572. doi: 10.1097/00004872-198710000-00009. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES